Aduro Biotech Announces Presentation of Phase 1 Data for LADD … – Markets Insider
|
Aduro Biotech Announces Presentation of Phase 1 Data for LADD …
Markets Insider BERKELEY, Calif., Oct. 17, 2017 (GLOBE NEWSWIRE) — Aduro Biotech, Inc. (Nasdaq:ADRO), a biopharmaceutical company with three distinct immunotherapy … |
